Beau lines, onychomadesis, and retronychia: A unifying hypothesis - 15/10/15
Doi : 10.1016/j.jaad.2015.08.003
Mark A. Braswell, DO a, C. Ralph Daniel, MD b, c, Robert T. Brodell, MD b, d, ⁎ 
a Kansas City University of Medicine and Biosciences, Kansas City, Missouri
b Department of Dermatology, University of Mississippi Medical Center, Jackson, Mississippi
c Department of Dermatology, University of Alabama-Birmingham, Birmingham, Alabama
d Department of Dermatology, University of Rochester School of Medicine and Dentistry, Rochester, New York
∗Correspondence to: Robert T. Brodell, MD, Department of Dermatology, University of Mississippi Medical Center, 2500 N State St, Jackson, MS 39216.
Abstract |
Beau lines, onychomadesis, and retronychia are nail dystrophies with distinctive clinical findings. Trauma has been reported as the initiating factor in each of these entities. Infections, severe medical illnesses, major surgery/anesthesia, medication side effects, and autoimmune disease can produce Beau lines and onychomadesis. This article illustrates the common underlying pathophysiological mechanism that produces each of these nail dystrophies.
Le texte complet de cet article est disponible en PDF.Key words : Beau lines, medication reactions, nail dystrophy, nails, onychomadesis, retronychia, trauma
Plan
| Dr Braswell is currently affiliated with the Transitional Year Residency Program at San Antonio Uniformed Services Health Education Consortium, Texas. |
|
| Funding sources: None. |
|
| Disclosure: Dr Brodell received honoraria from presentations for Allergan, Galderma Laboratories LP, and PharmaDerm, a division of Nycomed US Inc, and received consultant fees from Galderma Laboratories LP. He performed clinical trials for Genentech and Janssen Biotech Inc. Dr Daniel acts as a consultant for Meiji Seika Pharma Co Ltd, Polichem, Medimetriks Pharmaceuticals Inc, and Valeant Pharmaceuticals International. He is a stockholder in Medimetriks Pharmaceuticals Inc. Dr Braswell has no conflicts of interest to declare. |
|
| Reprints not available from the authors. |
© 2015
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 73 - N° 5
P. 849-855 - novembre 2015 Retour au numéro
Article précédent
- Acute generalized exanthematous pustulosis (AGEP): A review and update
- Jesse Szatkowski, Robert A. Schwartz
- Role of sebaceous glands in inflammatory dermatoses
- Vivian Y. Shi, Michael Leo, Lauren Hassoun, Dev S. Chahal, Howard I. Maibach, Raja K. Sivamani
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?